Indication · Obstetrics & Gynecology
Endometriosis and pelvic pain
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
3
Cleared or approved since 2000
PMA and De Novo
1
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
46
222 device trials in all
Devices
0 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
No devices on this pathway.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare UpsPivotal-lookingRecruiting
Samphire Group, Inc.Not on our public-company list
NCT06974773 · 120 participants (planned) · Start Dec 4, 2025 · Primary completion Jun 1, 2027
Device: NettleEndo; Sham NettleEndo Device · For: Endometriosis
Sites: San Francisco, California
221 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on endometriosis across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.